Extended release pharmaceutical formulations
US9675585B1 · kind B1 · utility
2Cited by
20References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 24, 2016 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | Mar 24, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/284
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to coated extended release pharmaceutical formulations of valsartan comprising a core comprising valsartan and at least one coating layer over the core. The present invention further relates to extended release pharmaceutical formulations comprising (a) a core comprising valsartan and at least one hydrophilic swelling polymer and (b) at least one coating layer over the core wherein the coating layer in contact with the core is applied from an organic solvent based system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.